Bridged bicyclic nitrogen scaffolds have a huge potential in drug discovery as these are conformational restricted analogues of important aminocarbo– and aminoheterocycles. However, long synthetic sequences relying on traditional organic chemistry currently limit the drug discovery process. New and shorter synthetic procedures are therefore required based on readily available starting materials. Several methods have been developed before for the construction of heterocyclic ring systems (e.g. indole, indoline, benzofuran etc.) via tandem reactions involving directed C(sp2)-H functionalization chemistry. However, procedures featuring a challenging directed C-C bond formation on unactivated C(sp3)-H are still rare. In this project, we developed the expedient formation of the normorphan core via a tandem catalysis approach involving intermolecular -C(sp3)-H olefination of DG equipped cyclohexanamines with 1,1-dibromo-1-alkenes followed by a ring closure reaction of intermediate 3-(1-bromo-1-alkenyl)cyclohexan-1-amine through a C(sp2)-Br amidation. This is a new, unknown in the state-of-the art approach to a construction of a bridged bicyclic nitrogen scaffold based on the C-H activation using a directing group (DG) with a potential impact on a drug discovery process in pharmaceutical industry.